The Food and Drug Administration announced Wednesday that it has approved over-the-counter sales of a nasal treatment for opioid overdoses for the first time.
The Food and Drug Administration approved selling Narcan, a leading naloxone product, without a prescription. Connecticut was among the first states to expand access to naloxone by training pharmacists as prescribers.